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Abstract
Background: Existing data on physical rehabilitation interventions in critical illness are challenged by outcome
heterogeneity that limits data synthesis and translation of research findings into clinical practice. This protocol
describes the PRACTICE study to develop a core outcome set (COS) for trials of physical rehabilitation interventions
delivered across the continuum of a patient’s recovery from the intensive care unit until reintegration in the
community following hospital discharge.
Methods: Mixed methods will be used including: systematic reviews of quantitative and qualitative literature;
qualitative interviews with patients and caregivers; a modified Delphi consensus process with researcher, clinician
and patient/caregiver stakeholder groups; and consensus meetings for ratification of findings, resolving uncertainty,
or developing an action plan for COS implementation.
Discussion: The PRACTICE COS will inform relevant stakeholders about important outcomes regarding physical
rehabilitation in critical illness, and may enhance the future design and conduct of trials in this area.
Trial registration: COMET database (www.comet-initiative.org/, Record ID 288, 01/03/13). PROSPERO database
(CRD42014008908, CRD42017078549).
Keywords: Physical rehabilitation, Core outcome set, Consensus, Critical illness, Outcome, Measurement
Background
Muscle dysfunction is characteristic in patients following
critical illness and is a significant driver underlying per-
sistent physical impairment. Survivors demonstrate deficits
in exercise capacity, physical function and health-related
quality of life related to physical status for up to 5 years
post index intensive care unit (ICU) admission [1–5]. In
recent years, the profile of physical rehabilitation in critical
illness to mitigate these complications has increased in the
UK supported by national guidelines [6, 7]. Furthermore, a
growing evidence base of randomised controlled trials
(RCTs) has investigated the effectiveness of physical re-
habilitation interventions including those delivered in the
ICU [8–14], following transfer to the ward [15, 16], post
hospital discharge [17–21], and across the recovery
pathway [22].
However, one major challenge to the interpretation of
existing data is heterogeneity in selection and definition
of outcomes used for evaluation. Often trials examining
similar interventions measure multiple, dissimilar out-
comes. For example, three recent major trials evaluating
enhanced exercise-based physical rehabilitation interven-
tions delivered in the ICU measured three [10], seven
[11], and 12 [14] outcomes; only one outcome was com-
mon across all three studies. The problem is that there
is currently no consensus on the most appropriate out-
comes for use in these trials [23]. Even the event of
consistency in outcome selection, there is often little
agreement with regard the measurement tool, timing of
assessment, and duration of follow-up; e.g. physical
function measured using the Six Minute Walk Test at
* Correspondence: Bronwen.connolly@nhs.net
1Lane Fox Clinical Respiratory Physiology Research Centre, Guy’s and St.
Thomas’ NHS Foundation Trust, London, UK
2NIHR Biomedical Research Centre at Guy’s and St. Thomas’ NHS Foundation
and King’s College London, London, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Connolly et al. Trials  (2018) 19:294 
https://doi.org/10.1186/s13063-018-2678-4
6 months [22] or measured using the Short Form-36
Physical Function subscale at 6 weeks post intervention
[21]. As evidenced in a recent Cochrane review examin-
ing exercise interventions after ICU discharge in survi-
vors of critical illness [24], outcome measure variability
impedes meta-analyses of outcomes to evaluate the ef-
fect of interventions and thus review evidence cannot
recommend guidance for clinical practice.
Establishing a ‘core outcome set’ (COS) is one strategy
to address the requirement for outcome transparency in
trials. A COS is an agreed, standardised collection of
outcomes that would be measured and reported, as a
minimum, in all clinical trials for a defined field of
interest [25, 26]. Importantly a COS does not preclude
researchers from measuring other outcomes of interest
relevant to the specific intervention, including the pri-
mary outcome. Rather, achieving consensus from key
stakeholders on priority outcomes would increase the
cumulative value of individual trials for informing
evidence-based clinical decision-making. Recent COSs
in the critical illness population have focussed on
long-term outcomes following hospital discharge in sur-
vivors of acute respiratory failure [27, 28], mechanical
ventilation [29], and delirium [30]. Outcome selection in
complex interventions, such as physical rehabilitation in
critical illness, is crucial [31]. At present there is no COS
for trials investigating physical rehabilitation interven-
tions at any stage of the recovery pathway for this pa-
tient population. The aim of the PRACTICE study,
therefore, is to develop a COS for trials of physical re-
habilitation interventions delivered across the con-
tinuum of recovery from within the ICU to hospital
discharge to the community.
Methods
Overview
A mixed-methods study adopting the process model
for COS development outlined by Williamson et al.
[25], integrating systematic reviews of quantitative and
qualitative literature, qualitative interviews with pa-
tients and caregivers (preparatory stage), a consensus
process to determine the COS (stage 1), establishing
appropriate measurement instruments for the COS
(stage 2), and finally dissemination (stage 3) (Fig. 1).
This protocol is developed in line with guidance from
the Core Outcome Measures in Effectiveness Trials
(COMET) Handbook [32], in keeping with methods
adopted by prior critical care-related COS [27–30], fol-
lows COS-STAD and COS-STAR (Core Outcome
Set-Standards for Development [33], and Reporting
[34]) recommendations. In addition PRACTICE is
supported by the International Forum for Acute Care
Trialists (http://www.infactglobal.org/about/).
The Steering Group consists of the study investiga-
tors, representing expertise in the field of critical care,
physical rehabilitation and COS development; two in-
dependent experts with relevant research and clinical
expertise; two patient/caregiver representatives; and an
independent statistician. We will use the COMET
Checklist for Public Research Partners and the COS
Study Developers Involved in Designing a COS study
Checklist [35] to facilitate engagement with external
Steering Group members during the study process. This
COS study is registered on the COMET database (http://
www.comet-initiative.org/studies/details/288?result=true).
Scope of the COS
The scope of PRACTICE will specifically apply as
follows:
1. Research or practice setting
Primarily for adoption in all research trials and clinical
studies evaluating physical rehabilitation interventions
including, but not restricted to, randomised and con-
trolled trials, comparative study designs with or without
concurrent controls, observational cohort studies and
case series
2. Health condition
Critical illness (life-threatening illness requiring treat-
ment in a high-acuity setting)
3. Population
Adult (≥ 18 years of age) patients who have experienced
critical illness
4. Interventions
Physical rehabilitation interventions include any form
of mobilisation, exercise, or adjuncts, such as cycling or
electrical muscle stimulation, and delivered across any
one or more stages of the continuum of recovery (within
the ICU, following ICU discharge, and following hospital
discharge to the community)
The PRACTICE study will identify core outcomes for
physical rehabilitation interventions delivered at any
stage of the recovery continuum, and this requires spe-
cial consideration. We recognise that different outcome
measurement instruments may be more appropriate as a
result of patients’ changing clinical status and perform-
ance ability as they recover and transition between
stages. This may necessitate the use of measurement in-
struments with more suitable psychometric properties to
appropriately reflect that change. We will further under-
stand the extent to which this is evident through data
acquired via our systematic reviews of quantitative and
qualitative literature, where outcome and outcome
measurement instrument data will be categorised ac-
cording to recovery stage, and the results of the consen-
sus process that identify the core outcomes for inclusion
in the set.
Connolly et al. Trials  (2018) 19:294 Page 2 of 8
Preparatory stage – information sources
This preparatory stage is vital to inform the selection of
outcomes for round 1 of the Delphi consensus. We will
conduct (1) systematic reviews of quantitative and qualita-
tive research literature related to physical rehabilitation in-
terventions in critical illness and (2) qualitative, individual,
semi-structured interviews with survivors of critical illness
and family/caregivers.
Systematic review of the trial literature
A full protocol is reported in Additional file 1 and regis-
tration (PROSPERO database, CRD42014008908, https://
www.crd.york.ac.uk/PROSPERO/). In brief, this review
will identify outcomes and associated measurement in-
struments reported in quantitative studies of physical re-
habilitation interventions across the recovery continuum.
Data extraction will follow Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) 2013
recommendations [36], comprehensively characterising
outcome reporting, including (1) detail and definition of
all primary and secondary outcomes, where reported, (2)
specific measurement variables, (3) participant-level ana-
lysis metrics, (4) methods of aggregation, and (5) specific
time points of measurement. Extracted outcomes will be
classified according to a taxonomy for COS development
[37] (Table 1), and summarised according to stage of the
recovery continuum.
Systematic review of the qualitative research literature
A full protocol is reported in Additional file 2 and review
registration (PROSPERO database, CRD42017078549,
https://www.crd.york.ac.uk/PROSPERO/). In brief, this
review will identify themes around patient experience of
recovery following critical illness across the recovery
continuum in relation to receipt of any physical rehabilita-
tion interventions. Patient-reported data that could be
Fig. 1 Flow diagram outlining PRACTICE core outcome set development. Stages of consensus for core outcome set and core outcome measurement
instruments are summarised. Hashed line (− − ->) indicates specific requirements for a consensus meeting determined on completion of the
consensus process
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considered a potential outcome relevant for the PRAC-
TICE COS will be extracted and mapped to the aforemen-
tioned taxonomy [37].
Qualitative interviews with patients and caregivers
Overview Meaningful patient and caregiver input into
the development of COSs is imperative for highlighting
priority outcomes from their perspective that may not
be considered by researchers and clinicians [38]. To fa-
cilitate this process we will conduct interviews with sur-
vivors of critical illness and caregivers to discuss
outcomes relevant to physical rehabilitation after critical
illness [39].
Study population We will include adult (≥ 18 years of
age) survivors of critical illness and caregivers with rec-
ollection of the recovery process (including receipt of
any physical rehabilitation). For pragmatic purposes,
only participants who are fluent in English and UK
based will be recruited for interview and we will exclude
patients from specialist populations who may have de-
fined rehabilitation pathways in place; e.g. neurological
injury or trauma. We will use purposive sampling [40],
ensuring maximum variation sampling [41], to reflect a
range of age, sex, disease/conditions, and ethnicities.
Participants will be identified via patient support groups,
charities, patient-focused network groups, snowballing,
and personal contacts. Recruitment will continue until
data saturation is achieved, defined as no new emergent
themes arising from subsequent interviews.
Data collection Semi-structured telephone interviews
will be conducted, overseen by an experienced qualita-
tive researcher. Telephone interviews remove the need
for an in-person visit either at the participant’s home,
hospital, or an alternative location, and enable wider
geographical spread of participants. Our interview guide
will be developed in conjunction with patient involvement.
We will explain the specific purpose of PRACTICE and
ask participants what outcomes were of importance, and
why, when considering physical rehabilitation in critical
illness. Interviews will be audio-recorded for accurate
transcription and data analysis.
Data analysis Interview transcripts will be analysed by
the research team using thematic analysis [42]. New
unique outcomes will be identified, confirmed as relevant
and categorised using the aforementioned taxonomy [37].
Summarising the information sources
An initial list of outcomes will be generated from the
systematic reviews of quantitative and qualitative litera-
ture, and qualitative interviews with patients and care-
givers. Lay descriptions will be provided, developed
with patient/caregiver Steering Group representatives,
in addition to any relevant medical terminology. Re-
sources, including plain-language summaries, provided
by the COMET Initiative will be used to introduce the
Delphi study. Pilot testing will be undertaken prior to
commencing the formal Delphi survey.
Stage 1 – Determining the COS
There is currently no ‘gold standard’ consensus tech-
nique to adopt when developing a COS, with a wide var-
iety in methods reported by COS developers [43]. The
Delphi technique is increasingly common [44], often
with an additional final consensus meeting. Delphi sur-
veys allow for anonymous opinions of participants to be
obtained in an objective and neutral manner, such that
all responses are given equal weight avoiding influence
of perceived values of the views of others, or dominance
by stronger individuals [45]. A further advantage of
adopting the modified Delphi technique for consensus is
that survey rounds can be completed electronically, such
that a much larger panel can be included than would be
feasible in a face-to-face meeting [45]. For repeated survey
rounds, this, therefore, becomes a more cost-effective
approach.
Participants, sample size, recruitment, and retention
The participant panel will comprise representatives from
three key stakeholder groups; ‘clinical researchers’, ‘clini-
cians’ ,and ‘patients/caregivers’. Optimal panel size to
achieve valid consensus in studies using the modified
Delphi technique is undetermined [46], influenced by as-
pects of practicality, analysis time and scope of the ques-
tion [47]. As large a panel as possible for each stakeholder
group will be recruited. Organisations for each stake-
holder group will be identified using existing networks of
national and international critical care contacts, and
Table 1 Abridged details of taxonomy developed for use in
core outcome set development
Core area Domain
Death Mortality/survival
Physiological or clinical aE.g. cardiac outcomes; nervous system
outcomes; respiratory, thoracic and
mediastinal outcomes
Life impact Functioningb; global quality of life;
perceived health status; delivery of carec;
personal circumstances
Resource use Economic; hospital; need for further
intervention; societal/carer burden
Adverse events Adverse events/effect
Abridged from Dodd et al. [37]. This taxonomy encompasses 38 domains
within 5 core areas. a23 specific domains relating to the underlying cause of
affected body system are reported for this core area; bFunctioning is expanded
to encompass physical, social, role, emotional and cognitive; cDelivery of care
includes; for example, acceptability and availability, withdrawal from treatment;
process, implementation and service outcomes
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web-based searches. Letters of invitation to participate will
be emailed to the relevant organisation leads or directly to
an individual (where applicable) outlining the study, antic-
ipated timelines for overall commitment and estimated
time required for completion of each survey round, and
requesting consent to participate.
To minimise attrition bias, which can overestimate de-
gree of consensus in the final results [45, 48], only partici-
pants responding favourably to the preliminary invitation
to participate will be recruited. During the course of the
Delphi survey rounds, strategies will be adopted to facili-
tate retention of participants including personalised invita-
tions and reminders about survey completion, contact
details for the lead researcher, regular checks to verify and
update contact details and optimising elements of the on-
line survey including interface, conciseness and speed of
completion. A unique identifier will be assigned to each
participant to facilitate personalised monitoring of survey
completion. The primary means of contact with partici-
pants will be via email; however, we will collect a
secondary form of contact detail to facilitate sending
survey completion reminders.
‘Researcher’ stakeholder group This group will com-
prise members from each of the clinical trial group or-
ganisations of InFACT, supplemented by senior or
corresponding authors from physical rehabilitation
publications identified in the systematic review of quan-
titative literature.
‘Clinician’ stakeholder group Clinicians will be re-
cruited from international professional organisations
relevant to critical care; e.g. physiotherapy, critical care
medicine. Clinicians will have a primary role in clinical
practice and be medical clinicians at consultant level (or
equivalent), and nursing and allied health professionals
with at least 3 years’ specialist experience in critical care.
‘Patient/caregiver’ stakeholder group This group will
comprise members of patient and public involvement
and engagement groups, patient support groups, char-
ities, or organisations, patient-focused network groups,
and personal contacts.
Modified Delphi methodology for consensus Partici-
pants will score each outcome according to the Grading
of Recommendations Assessment, Development, and
Evaluation (GRADE) scale [49], ranging 1–9 in terms of
importance for inclusion in the final COS (1–3, not
important for inclusion; 4–6, important but not critical;
7–9, critical for inclusion). Participants will also be pro-
vided with an ‘Unable to score’ response if they consider
themselves unable to rate any outcome. Consensus for
inclusion by a particular stakeholder group will be
defined as ≥ 70% of responses rating the outcome as
‘critical’, i.e. GRADE score of 7 or greater, and less than
or equal to 15% of responses rating the outcome ≤ 3 on
the GRADE scale, i.e. ‘not important’. Participants will
be asked to complete survey rounds within 7 days of re-
ceipt; non-respondents will receive reminders for survey
completion during an overall survey window of 3 weeks
from the original email.
Stage 1, Round 1; consensus on core outcomes, i.e.
‘what’ to measure At the start of Round 1, demographic
data (including age, sex, country of residence, duration
of clinical and/or research experience, involvement in
physical rehabilitation research) will be collected to
characterise participants. The Round 1 questionnaire
will be structured so that outcomes common to all
stages of the recovery continuum will be listed first,
followed by outcomes that are specific to individual time
points. Within this structure, the order of outcomes will
be randomised. For each outcome, participants will rate
its importance for inclusion in the PRACTICE COS.
Additionally, participants will be able to provide
text-based comments and/or additional outcomes for
consideration.
Stage 1, Rounds 2 and 3 Outcomes meeting consensus
for ‘not important for inclusion’ will be removed to
maximise efficiency by avoiding re-scoring of redundant
outcomes. Remaining outcomes, and new outcomes
identified from Round 1, will be carried forward into
Round 2. Each participant will be shown their own score
from Round 1 and will receive feedback on the average
scores from each of the three stakeholder groups [50],
and will be asked to re-score the outcome considering
this feedback. Participants will have the opportunity to
report reasons for any change of score that alters the
overall category of importance rating. A third Delphi
round will be conducted for new outcomes identified in
Round 1 and which do not reach consensus in Round 2,
thus allowing for two rounds of rating importance.
Consensus meetings In-person, telephone, or webinar
consensus meetings may be held to ratify final COS con-
tents or undertake any additional voting, e.g. in the
event that the number of outcomes reaching consensus
for inclusion in the COS is perceived to be too many.
However there is minimal evidence for the recom-
mended delivery of such meetings [32]. The Steering
Group will first review the findings of the consensus
process for establishing the COS to determine the re-
quirements for a consensus meeting and its structure,
format, and content. Attendees at consensus meetings
will comprise a random 10% selection of Delphi partici-
pants from each stakeholder group.
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Nested methodological questions A number of nested
methodological questions will be examined during
PRACTICE involving exploratory secondary analyses of
the process and dataset. These questions are outlined
below, with further details reported in Additional file 3:
1. Which outcomes in the final PRACTICE COS
originated from which information sources?
2. How does the final PRACTICE COS feature in existing
trials of physical rehabilitation in critical illness?
3. How did different stakeholder groups rate
outcomes?
Stage 2 – Establishing core outcome measurement
instruments
When the PRACTICE COS is finalised, we will then de-
termine how to measure the outcomes in the set. We
will search existing resources where the outcome measures
may have already achieved consensus; e.g. the ImproveLTO
(Long Term Outcomes) repository (www.improvelto.com/),
and/or other systematic reviews of measurement instru-
ments and published COSs in critical illness. In cases where
outcome measures have not already been defined and
agreed, we will collate the candidate measurement instru-
ments and undertake a repeat Delphi study using the afore-
mentioned methodology. Participants will be provided with
‘Instrument cards’ to accompany each round in inform
decision-making around importance of each outcome
measurement instrument. Instrument cards will include de-
scriptions of the instruments, instructions for instrument
completion, feasibility of use, psychometric properties for
use in the target population and pragmatic items such as
cost and licensing requirements. The Instrument cards will
be developed in conjunction with www.improvelto.com/ re-
sources, updating existing and generating new cards where
necessary. When determining psychometric properties of
measurement instruments, we will review existing system-
atic reviews of relevant articles in the target population and
systematically search for any new relevant studies. We will
use the COnsensus-based Standards for the selection of
health Measurement Instruments (COSMIN) to assess the
methodological quality of new evidence [51] in keeping
with COSMIN guidelines for selecting outcome measure-
ment instruments in COSs [52]. Where outcomes do not
require an instrument measure, definitions will be provided
reflecting recommended components [36].
Consensus meetings Findings of the consensus process
for determining measurement instruments will be simi-
larly reviewed by the Steering Group for requirements for
an additional consensus meeting to ratify findings, or, for
example, if there is uncertainty around any outcome meas-
urement instrument. Any consensus meeting will be con-
ducted as described in stage 2.
Stage 3 - Strategies for dissemination
Multiple formats of dissemination will be employed includ-
ing peer-reviewed, open access publications, presentation
at national and international conferences, engagement with
Journal editors, representatives from national and inter-
national funding agencies and policy-makers, and sum-
maries (lay and professional versions) for circulation
through relevant patient and professional (clinical and
research) organisations and networks. In addition we
will explore dissemination of study findings via national
research infrastructure, healthcare decision-making or-
ganisations, e.g. Cochrane, and social media. We will
also circulate the final COS via all panel members for
their wider dissemination.
Data management and analysis
All Delphi survey rounds will be delivered electronic-
ally using DelphiManager software (COMET Initiative,
University of Liverpool, UK). Confidentiality of gener-
ated data will be ensured by individual participants’ al-
location of unique identifiers, and data storage on
secure, encrypted institutional servers. Response rates
will be defined as the proportion of recruited partici-
pants who completed each survey round, and reported
for each stakeholder group. Descriptive statistics will be
used to analyse and summarise survey round responses,
using GraphPad Prism version 7.0d (GraphPad Software,
La Jolla, CA, US, www.graphpad.com).
Ethics
Individual participants will respond to recruitment
advertisements, will be approached directly or will
self-volunteer following nomination through their affili-
ated organization. Participants will receive a specific par-
ticipant information sheet. Verbal informed consent will
be acquired for those participants in the qualitative in-
terviews. For Delphi consensus survey rounds, which
will be conducted entirely online, agreement to partici-
pate and completion of the surveys will be considered
indicative of consent. This study has been approved by
the King’s College London BDM (Biomedical Sciences,
Medicine, Dentistry, and Natural and Mathematical
Sciences) Research Ethics Panel (LRS-17/18–4603), and
the UK Health Research Authority National Research
Ethics Service North-East Committee (18/NE/0018).
Discussion
The PRACTICE COS study will follow robust and rec-
ommended methodology for its development, including
approaches currently adopted by other COS in the
critical care specialty to identify core outcomes and
their measurement instruments for trials of physical
rehabilitation in critical illness. Important stakeholder
groups (researcher, clinicians, patients/caregivers) will
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be included. It is anticipated that adoption of the
PRACTICE COS will enhance the design, conduct, and
evaluation of future trials in this area.
Trial status
The systematic reviews of quantitative and qualitative lit-
erature have been completed, and recruitment is currently
underway for the qualitative interviews. Delphi consensus
participants are currently being identified and recruited.
Additional files
Additional file 1: Protocol for systematic review of quantitative
research. (DOCX 23 kb)
Additional file 2: Protocol for systematic review of qualitative research.
(DOCX 18 kb)
Additional file 3: Nested methodological questions. (DOCX 13 kb)
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